Related Experiment Video
Updated: Feb 14, 2026

Detecting Behavioral Deficits in Rats After Traumatic Brain Injury
Published on: January 30, 2018
EPO improved neurologic outcome in rat pups late after traumatic brain injury
Michelle E Schober1, Daniela F Requena1, Christopher K Rodesch2
1Department of Pediatrics, Division of Critical Care, University of Utah, Salt Lake City, UT 84132, United States.
Insights
Erythropoietin treatment improved long-term object recognition in young rats after traumatic brain injury. This cognitive improvement was linked to preserved hippocampal volume, not neuronal count, suggesting therapeutic potential.
Area of Science:
- Neuroscience
- Developmental Biology
- Pharmacology
Background:
- Traumatic brain injury (TBI) in developing brains poses significant long-term risks.
- Erythropoietin (EPO) shows promise in treating TBI, with known effects on Brain-Derived Neurotrophic Factor (BDNF).
- Long-term data on EPO's effects on developmental TBI, BDNF, histology, and cognition are limited.
Purpose of the Study:
- To investigate the long-term effects of erythropoietin on cognitive function and brain structure after developmental TBI in rats.
- To determine if EPO administration impacts Brain-Derived Neurotrophic Factor (BDNF) levels and hippocampal neuronal preservation.
- To assess the correlation between EPO treatment, cognitive outcomes, and histological changes post-TBI.
Main Methods:
- Controlled cortical impact model in 17-day-old rat pups to induce TBI.
- Administration of erythropoietin or vehicle at multiple time points post-injury.
- Histological analysis at 35 days, Novel Object Recognition testing in adulthood, and BDNF measurements.
Main Results:
- Erythropoietin treatment significantly improved Novel Object Recognition performance in adulthood.
- Histological analysis revealed preserved hippocampal volume in EPO-treated rats.
- Neuronal fraction in the hippocampus was not significantly different between groups, despite improved cognition.
Conclusions:
- Improved object recognition following erythropoietin treatment is associated with preserved hippocampal volume after developmental TBI.
- These findings support further investigation into erythropoietin as a therapeutic agent for pediatric TBI.
- EPO's potential benefits in neonatal hypoxic-ischemic injury suggest a broader role in developmental brain injury.
Abstract:
In adult rats, erythropoietin improved outcomes early and late after traumatic brain injury, associated with increased levels of Brain Derived Neurotrophic Factor. Using our model of pediatric traumatic brain injury, controlled cortical impact in 17-day old rats, we previously showed that erythropoietin increased hippocampal neuronal fraction in the first two days after injury. Erythropoietin also decreased activation of caspase3, an apoptotic enzyme modulated by Brain Derived Neurotrophic Factor, and improved Novel Object Recognition testing 14 days after injury. Data on long-term effects of erythropoietin on Brain Derived Neurotrophic Factor expression, histology and cognitive function after developmental traumatic brain injury are lacking. We hypothesized that erythropoietin would increase Brain Derived Neurotrophic Factor and improve long-term object recognition in rat pups after controlled cortical impact, associated with increased neuronal fraction in the hippocampus.
Methods:
Rats pups received erythropoietin or vehicle at 1, 24, and 48 h and 7 days after injury or sham surgery followed by histology at 35 days, Novel Object Recognition testing at adulthood, and Brain Derived Neurotrophic Factor measurements early and late after injury.
Results:
Erythropoietin improved Novel Object Recognition performance and preserved hippocampal volume, but not neuronal fraction, late after injury.
Conclusions:
Improved object recognition in erythropoietin treated rats was associated with preserved hippocampal volume late after traumatic brain injury. Erythropoietin is approved to treat various pediatric conditions. Coupled with exciting experimental and clinical studies suggesting it is beneficial after neonatal hypoxic ischemic brain injury, our preliminary findings support further study of erythropoietin use after developmental traumatic brain injury.
Related Concept Videos
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Traumatic Memory
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Post-traumatic Stress Disorder
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Improving Translational Accuracy

